WATERLOO, Belgium, May 13, 2010 /PRNewswire/ —
– State-of-the-Art Irrigated Ablation Catheter Offers a Unique
Design and Industry Leading Cooling Efficiency
Biosense Webster, Inc., a worldwide leader in the diagnosis and
treatment of cardiac arrhythmias, announced today the completion of
the first clinical cases with the new THERMOCOOL(R) SF Irrigated
Ablation catheter in the European Union, following recent CE Mark
approval. The THERMOCOOL(R) SF catheter is the most advanced
Biosense Webster irrigated ablation catheter for use by
electrophysiologists in treating cardiac arrhythmias, commonly
referred to as irregular heart rhythms.
The THERMOCOOL (R) SF Irrigated catheter is the next generation
in irrigated ablation catheters and builds upon the industry
leading THERMOCOOL(R) irrigated catheter platform. The THERMOCOOL
(R) SF catheter’s unique design and porous tip technology provides
EPs with uniform cooling across the entire catheter tip and allows
efficient cooling at half the flow rate.
“The THERMOCOOL(R) SF Irrigated Catheter is the latest
advancement in irrigated ablation catheter design with its
groundbreaking and unique porous tip technology,” said Shlomi Nachman, Worldwide President,
Biosense Webster, Inc. “This innovation further builds upon our
clear leadership position in the electrophysiology market and
reinforces our long-standing commitment to electrophysiologists and
their patients. “We are extremely pleased this exciting new product
will be launched throughout the European Union over the coming
months.”
Unlike competitive irrigated technologies which offer localized
cooling, the cutting edge catheter design and breakthrough porous
tip technology of the
‘/>”/>
